GSK – Rockville Biopharmaceutical Manufacturing Plant Expansion – Maryland - Project Profile
"GSK – Rockville Biopharmaceutical Manufacturing Plant Expansion – Maryland - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts.
The "GSK – Rockville Biopharmaceutical Manufacturing Plant Expansion – Maryland - Project Profile" is part of Timetric's database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders.
GlaxoSmithKline plc (GSK) plans to undertake the expansion of its manufacturing plant in Maryland, the US.
The project involves the expansion of a manufacturing plant. It includes the construction of laboratories, production units, vacuum chambers, storage facilities and parking facilities and the installation of machines and equipment.
On May 1, 2017, GSK unveiled the plans for the expansion of its manufacturing plant. The final investment decision is expected in the end of 2017.
The project is in the early stages of development. Construction is expected to be completed by 2019.
The project involves the expansion of its manufacturing plant in Rockville, Maryland, the US.
The US$139 million project includes the following:
1. Construction of laboratories
2. Construction of production units
3. Construction of vacuum chambers
4. Construction of storage facilities
5. Construction of parking facilities
6. Installation of machines and equipmentReasons To Buy